analyst
GM
NYSE · GMED
Globus Medical, Inc.
Healthcare · Medical - Devices
$75.19
Down-$1.23 (-1.64%)
Updated Sep 23, 2026, 11:15 PM
SID Score
5.1/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 11.89B
- P/E ratio
- 28.2
- Dividend yield
- 0.00%
- 52-week range
- $54.15 – $101.40
- Volume
- 1.93M
- Avg. volume
- 1.73M
Price performance
GMED price history
1M range · 20 trading sessions · Daily adjusted prices
GMED closed at $75.19 after 20 trading sessions, down 9.37% for the selected period.
- Last close
- $75.19
- Period change
- -9.37%
- Period low
- $73.56
- Period high
- $83.10
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $74.99 | $75.73 | $74.3694 | $75.19 | 1.93M |
| Sep 21, 2026 | $74.00 | $74.41 | $73.17 | $74.29 | 1.25M |
| Sep 18, 2026 | $73.94 | $75.03 | $73.54 | $74.08 | 2.9M |
| Sep 17, 2026 | $75.76 | $76.19 | $74.15 | $74.16 | 1.42M |
| Sep 16, 2026 | $74.64 | $76.10 | $74.5794 | $75.26 | 1.33M |
| Sep 15, 2026 | $75.48 | $75.71 | $74.17 | $74.69 | 1.94M |
| Sep 14, 2026 | $74.95 | $76.89 | $74.73 | $75.77 | 1.97M |
| Sep 11, 2026 | $74.42 | $74.535 | $73.12 | $74.19 | 1.49M |
| Sep 10, 2026 | $74.01 | $74.49 | $72.84 | $73.56 | 1.49M |
| Sep 9, 2026 | $74.51 | $75.51 | $74.01 | $74.52 | 1.52M |
| Sep 8, 2026 | $77.79 | $78.29 | $74.95 | $75.04 | 1.89M |
| Sep 4, 2026 | $77.23 | $78.685 | $77.07 | $78.29 | 1.12M |
| Sep 3, 2026 | $81.105 | $81.54 | $78.04 | $78.12 | 1.4M |
| Sep 2, 2026 | $80.23 | $82.45 | $80.025 | $80.66 | 826.12K |
| Sep 1, 2026 | $81.46 | $82.89 | $79.69 | $80.48 | 1.05M |
| Aug 31, 2026 | $82.07 | $82.145 | $81.00 | $81.37 | 1.03M |
| Aug 28, 2026 | $82.61 | $83.53 | $81.80 | $82.97 | 1.06M |
| Aug 27, 2026 | $82.02 | $84.01 | $81.67 | $82.54 | 846.24K |
| Aug 26, 2026 | $82.50 | $83.855 | $81.81 | $83.10 | 970.83K |
| Aug 25, 2026 | $83.99 | $84.4992 | $82.96 | $82.96 | 1.02M |
Latest GMED news
The latest Smart Investors Daily articles mentioning GMED.
Stock researchResearch & News · Competitors
Loading stock research…